Latest / PETRI DISH PERSPECTIVES
Episode 19: AstraZeneca
Send us Fan Mail
In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead explores the remarkable journey of AstraZeneca, from its unlikely Swedish-British merger to blockbuster drugs like Nexium and Crestor, through near-decline, and ultimately its reinvention as a science-driven leader in oncology, cardiometabolic health, and global public health.
Discover how bold leadership, high-risk bets, and groundbreaking discoveries like Tagrisso, Enhertu, and Farxiga transformed AstraZeneca into one of today’s most innovative pharmaceutical giants.
🎧 Listen now, stay curious, and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.